Biocardia's conference call today, monday, march 31, 2025 to be held at 4:30pm edt time today

Sunnyvale, calif., march 31, 2025 (globe newswire) -- biocardia, inc. [nasdaq: bcda], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today clarifies that two-year cardiamp-hf results will be addressed in a conference call scheduled for today, monday, march 31, 2025 at 4:30pm edt. the press release earlier this morning incorrectly noted the call would be held at 4:30pm pdt.
BCDA Ratings Summary
BCDA Quant Ranking